CL Item
Complete Response (CR) (1)
C0677874 (UMLS CUI-1)
CL Item
Complete Response with Incomplete Platelet Recovery (CRp) (2)
C3890735 (UMLS CUI-1)
CL Item
Complete Response with Incomplete Bone Marrow Recovery (CRi) (3)
C3538993 (UMLS CUI-1)
CL Item
Partial Response (PR) (4)
C1521726 (UMLS CUI-1)
CL Item
Stable Disease (5)
C0677946 (UMLS CUI-1)
CL Item
Progression (End of study, if if intake of Pazopanib for more than 7 days) (6)
C1335499 (UMLS CUI-1)
CL Item
Recurrent Disease (7)
C0277556 (UMLS CUI-1)
CL Item
unknown (8)
C0439673 (UMLS CUI-1)
CL Item
other (9)
C0205394 (UMLS CUI-1)